Bray Capital Advisors’s iShares US Pharmaceuticals ETF IHE Stock Holding History

Bray Capital Advisors’s Portfolio IHE Stock Details IHE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q4	–	Sell	-4,875	Closed	-$241K	–	210
2015 Q3	$241K	Hold	4,875	–	–	0.15%	110
2015 Q2	$284K	Hold	4,875	–	–	0.16%	113
2015 Q1	$280K	Hold	4,875	–	–	0.17%	119
2014 Q4	$246K	Buy	+4,875	New	+$238K	0.16%	126

Other funds holding IHE

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

LPL Financial San Diego, California $377B AUM 19.32% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

AWA

ARS Wealth Advisors St. Petersburg, Florida $556M AUM 30.03% 1-Year Est. Return

Brown Advisory Baltimore, Maryland $60.9B AUM 15.24% 1-Year Est. Return

SFI

SPC Financial Inc Rockville, Maryland $1.28B AUM 12.6% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Bray Capital Advisors's IHE Position: Q4 2015 in Review

Bray Capital Advisors sold out of iShares US Pharmaceuticals ETF (IHE) in Q4 2015, closing a stake of 4,875 shares — an estimated $241K sold.

Bray Capital Advisors first reported a position in IHE in Q4 2014 and held it in 4 quarters. The position peaked at $284K in Q2 2015. 103 funds tracked by Wall St. Rank hold IHE as of Q4 2015.

Bray Capital Advisors reported no remaining iShares US Pharmaceuticals ETF position as of Q4 2015 after selling out during the quarter.
Bray Capital Advisors sold 4,875 iShares US Pharmaceuticals ETF shares in Q4 2015, an estimated $241K.
Bray Capital Advisors first reported a position in iShares US Pharmaceuticals ETF in Q4 2014 and held it in 4 quarters.
Bray Capital Advisors's iShares US Pharmaceuticals ETF position peaked at $284K in Q2 2015.
103 funds tracked by Wall St. Rank held iShares US Pharmaceuticals ETF as of Q4 2015.

Based on Bray Capital Advisors's 13F filing for Q4 2015, filed 1 Feb 2016.